Marchex Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Edenbrook Capital, LLC, was filed 27 Mar 2025.
Marchex Inc: what insiders have been doing
Marchex Inc, classified in the Media & Communication sector, is a listed company based in Seattle, United States, founded in 2003. Its insiders report their share dealings to SEC (Form 4). Between 24 October 2025 and 24 October 2026, 3 insiders published 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Over the last twelve months, not one insider purchase of Marchex Inc stock was filed.
For context, the typical company on the same exchange (median of 3,167 companies) published 24 filings over the same period, against 3 filings here. The full history, which starts in 2006, counts 467 purchases against 506 sales. The 10-K for the year ended 31 December 2025 shows 45.4 m USD of revenue and -5.2 m USD of net income.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -7.1%Entry US$1.68 · Close at T+365 US$1.56
- -15.9%Entry US$1.70 · Close at T+365 US$1.43
- -25.1%Entry US$1.83 · Close at T+365 US$1.37
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 87,500 sharesClass B Common StockSEC:0001193125-26-117660:0
- 7,500 sharesClass B Common StockSEC:0001193125-26-117659:0
- 62,500 sharesClass B Common StockSEC:0001193125-26-117658:0
- 30,962 shares@ US$1.70620.2% of flowClass B common stockSEC:0001062993-25-006422:1Canonical exit: 24 Jun 2025 (T+90)
- 2,316 shares@ US$1.690.0% of flowClass B Common StockSEC:0001062993-25-006422:2Canonical exit: 25 Jun 2025 (T+90)
- 69,197 shares@ US$1.74995.1% of flowClass B Common StockSEC:0001062993-25-006422:0Canonical exit: 23 Jun 2025 (T+90)
- 4,980 shares@ US$1.731.7% of flowClass B Common StockSEC:0000950170-24-128606:1Canonical exit: 16 Feb 2025 (T+90)
- 807 shares@ US$1.69880.5% of flowClass B Common StockSEC:0000950170-24-128606:0Canonical exit: 13 Feb 2025 (T+90)
- 100,000 shares@ US$1.7335.5% of flowClass B Common StockSEC:0000950170-24-127591:1Canonical exit: 12 Feb 2025 (T+90)
- 5,571 shares@ US$1.76053.3% of flowClass B Common StockSEC:0000950170-24-127591:0Canonical exit: 11 Feb 2025 (T+90)
- 18,500 shares0Class B Common StockSEC:0000950170-24-099105:0
- 2,000 shares@ US$2.040.8% of flowClass B Common StockSEC:0000950170-24-098534:1Canonical exit: 13 Nov 2024 (T+90)
- 33 shares@ US$2.050.0% of flowClass B Common StockSEC:0000950170-24-098534:2Canonical exit: 13 Nov 2024 (T+90)
- 1,367 shares@ US$2.050.5% of flowClass B Common StockSEC:0000950170-24-098534:3Canonical exit: 13 Nov 2024 (T+90)
- 200 shares@ US$2.060.1% of flowClass B Common StockSEC:0000950170-24-098534:4Canonical exit: 13 Nov 2024 (T+90)
- 150 shares@ US$2.030.1% of flowClass B Common StockSEC:0000950170-24-098534:5Canonical exit: 14 Nov 2024 (T+90)
- 200 shares@ US$2.040.1% of flowClass B Common StockSEC:0000950170-24-098534:6Canonical exit: 14 Nov 2024 (T+90)
- 200 shares@ US$2.060.1% of flowClass B Common StockSEC:0000950170-24-098534:7Canonical exit: 14 Nov 2024 (T+90)
- 67 shares@ US$2.050.0% of flowClass B Common StockSEC:0000950170-24-098534:8Canonical exit: 17 Nov 2024 (T+90)
- 1,385 shares@ US$2.060.5% of flowClass B Common StockSEC:0000950170-24-098534:9Canonical exit: 17 Nov 2024 (T+90)
- 1,735 shares@ US$2.031.2% of flowClass B Common StockSEC:0000950170-24-098534:0Canonical exit: 13 Nov 2024 (T+90)
- 200,000 shares@ US$1.3689.8% of flowClass B Common StockSEC:0000950170-24-069349:0Canonical exit: 2 Sept 2024 (T+90)
- 336 shares@ US$1.350.1% of flowClass B Common StockSEC:0000950170-24-062836:1Canonical exit: 18 Aug 2024 (T+90)
- 164 shares@ US$1.340.0% of flowClass B Common StockSEC:0000950170-24-062836:2Canonical exit: 18 Aug 2024 (T+90)
- 120 shares@ US$1.3450.1% of flowClass B Common StockSEC:0000950170-24-062836:0Canonical exit: 18 Aug 2024 (T+90)
25 of 1283 declarations
About Marchex Inc
Marchex, Inc. (NASDAQ: MCHX) is a United States-listed company traded on the NASDAQ market, with its principal base in Seattle, Washington. Incorporated in 2003, Marchex has evolved from its earlier roots into a focused AI and conversational intelligence platform provider. The company’s current strategy centers on turning customer conversations into actionable business intelligence, helping enterprises improve revenue generation, customer experience, and marketing efficiency. For investors in French-speaking markets, it is best understood as a specialized software and data analytics business rather than a broad-based digital advertising company.
Marchex’s core offering is built around AI-powered conversation intelligence. Its platform analyzes phone calls, text messages, and other communication channels to extract insights for sales, marketing, service, operations, and executive teams. The company says its goal is to create intelligence around all types of business conversations and to help organizations convert prospects into customers more effectively. Key product capabilities include call tracking, conversational analytics, lead qualification, sentiment and summary generation, attribution, and industry-specific analytics. In practical terms, Marchex helps companies understand what customers are asking, why they convert, where revenue is lost, and which marketing channels are producing value.
Read moreShow less
The company’s competitive position is shaped by its vertical-market approach. Rather than offering a generic speech analytics tool, Marchex emphasizes prescriptive analytics tailored to specific industries and B2B2C use cases. This vertical focus can be an important differentiator in a crowded market for AI, contact-center software, and martech solutions. Marchex has highlighted a particularly strong footprint in automotive, stating that it supports more than 5,000 U.S. dealerships, while also expanding into healthcare and senior living. That sector specialization can make the platform more relevant to customers with complex workflows and measurable conversion outcomes.
Marchex’s main solutions include Engage for Sales and Service, conversational analytics tools, Call Summary and Sentiment Suite, and newer AI-driven initiatives such as AgentAI Optimizer and Marchex GPT. The company has also been rolling out vertical offerings for healthcare, senior living, and automotive customers, reflecting a strategy of layering industry-specific applications on top of its core data and AI infrastructure. Geographically, the business remains primarily focused on the United States, with offices in Seattle and Wichita and a customer base concentrated in U.S. enterprise verticals.
Recent developments show an active product and go-to-market phase. In 2025, Marchex reported new product launches, a unified user interface, and an expanded partnership with FordDirect that extends access to more than 3,000 franchised dealers. In 2026, it announced new integrations for healthcare marketing and continued showcasing of its platform at industry events. Overall, Marchex appears to be positioning itself as a niche public AI-conversation-intelligence company with long operating history, a verticalized product strategy, and growing emphasis on measurable business outcomes.
